Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Study to Examine the Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

NCT02299557 is registered in ClinicalTrials.gov with RDD Pharma Ltd as lead sponsor.

NCT NCT02299557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02299557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Study to Examine the Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients
Lead sponsor
RDD Pharma Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2014
Completion date
July 31, 2015
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence, spinal cord injury